🦊/Lists

Biotech Investors & VC Firms in United States

1280 firms in this list, with a median first check of $500K. 281 of them lead rounds. Generated from verified public data and updated continuously.

Soul Ventures
Series C–Late Stage
15 people
Blindspot Ventures Management Co
BostonPre-Seed–Late Stage
5 people
BioStar Capital
CharlevoixSeed–Late Stage$250K – $3M
10 people
Emergent Medical Partners, LLP
San JoseSeed–Series A
4 people
Luma Group
New YorkSeed–Late Stage
13 people
New Jersey Economic Development Authority
TrentonPre-Seed–Growth
13 people
Venture Capital Investment Management
San FranciscoSeed–Series A
7 people
Xcellerant Ventures
ScottsdalePre-Seed–Series A
13 people
Asia2G Capital
Silicon ValleyPre-Seed–Series A
6 people
Fab Co-Creation Studio Ventures
San FranciscoPre-Seed–Series A$250K – $1M
3 people
The Vertical Group
Berkeley HeightsPre-Seed–Series B$250K – $5M
4 people
Ying Fund
Los AngelesSeed–Series B
7 people
Verge Fund
AlbuquerquePre-Seed–Series A$100K – $500K
9 people
Crossbeam Venture Partners
New YorkPre-Seed–Late Stage$1M – $1.5M
5 people
Endeavor8
San Francisco
11 people
Lemhi Ventures
JordanSeed–Late Stage$500K – $5M
5 people
3CC | Third Culture Capital
BostonPre-Seed–Series A$250K – $1M
6 people
Character
MilwaukeePre-Seed–Series A$2M
3 people
Sv Tech Ventures, Inc.
Palo AltoPre-Seed–Series A
9 people
Taiho Ventures, LLC
Menlo ParkSeed–Series B
6 people
Avalo Therapeutics
Wayne
20 people
Global BioAccess Fund
New YorkSeries A–Late Stage$10M
11 people
IPD Capital
AventuraSeed–Series B
8 people
Polaris Partners
BostonSeed–Growth
14 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.